Sumitomo Mitsui Trust Group
CRL icon

Sumitomo Mitsui Trust Group’s Charles River Laboratories CRL Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Buy
2,848
+242
+9% +$44.9K ﹤0.01% 935
2025
Q4 		$520K Sell
2,606
-1,188
-31% -$215K ﹤0.01% 946
2025
Q3 		$594K Sell
3,794
-687
-15% -$109K ﹤0.01% 920
2025
Q2 		$680K Buy
4,481
+2,340
+109% +$312K ﹤0.01% 891
2025
Q1 		$322K Sell
2,141
-122,956
-98% -$20.6M ﹤0.01% 978
2024
Q4 		$23.1M Buy
125,097
+13,102
+12% +$2.52M 0.02% 621
2024
Q3 		$22.1M Buy
111,995
+3,714
+3% +$772K 0.02% 627
2024
Q2 		$22.4M Sell
108,281
-9,817
-8% -$2.22M 0.02% 615
2024
Q1 		$32M Sell
118,098
-1,940
-2% -$463K 0.02% 612
2023
Q4 		$28.4M Sell
120,038
-2,240
-2% -$441K 0.02% 636
2023
Q3 		$24M Sell
122,278
-115
-0.1% -$23.6K 0.02% 658
2023
Q2 		$25.7M Sell
122,393
-18,726
-13% -$3.73M 0.02% 654
2023
Q1 		$28.5M Sell
141,119
-1,066
-0.7% -$242K 0.02% 646
2022
Q4 		$31M Sell
142,185
-615
-0.4% -$134K 0.02% 629
2022
Q3 		$28.1M Sell
142,800
-1,472
-1% -$318K 0.02% 642
2022
Q2 		$30.9M Buy
144,272
+7,848
+6% +$1.92M 0.02% 643
2022
Q1 		$38.7M Sell
136,424
-895
-0.7% -$276K 0.03% 606
2021
Q4 		$51.7M Sell
137,319
-4,714
-3% -$1.83M 0.03% 528
2021
Q3 		$58.6M Sell
142,033
-7,240
-5% -$3.01M 0.04% 496
2021
Q2 		$55.2M Buy
+149,273
New +$49.8M 0.03% 526
2021
Q1 		– Sell
-14,682
Closed -$3.67M – 1157
2020
Q4 		$3.67M Buy
+14,682
New +$3.5M ﹤0.01% 856

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sumitomo Mitsui Trust Group's CRL Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group increased its Charles River Laboratories (CRL) stake by 9.3% in Q1 2026, buying an estimated $44.9K and bringing the position to 2,848 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Sumitomo Mitsui Trust Group first reported a position in CRL in Q4 2020 and has held it in 21 quarters since. The position peaked at $58.6M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 2,848 shares of Charles River Laboratories worth $491K as of Q1 2026.
  • Sumitomo Mitsui Trust Group bought 242 Charles River Laboratories shares in Q1 2026, an estimated $44.9K.
  • Charles River Laboratories made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #935 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Charles River Laboratories in Q4 2020 and has held it in 21 quarters since.
  • Sumitomo Mitsui Trust Group's Charles River Laboratories position peaked at $58.6M in Q3 2021.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.